Idiopathic inflammatory myopathies (IIMs) are a group of acquired muscle diseases with
muscle inflammation, weakness, and other extra-muscular manifestations. IIMs can …

Inclusion body myositis (IBM) is an acquired idiopathic inflammatory myopathy more
commonly seen in individuals aged above 50. Unlike other idiopathic inflammatory …

Sporadic inclusion body myositis (sIBM) is a heterogeneous progressive inflammatory
muscle disease impacting skeletal muscles in the head, neck, and limbs. Use of valid …

Novel immunotherapies are increasingly being used to treat malignant melanoma. The use
of such agents has been associated with triggering autoimmunity. However, there has been …

OBJECTIVES: Sporadic inclusion body myositis (IBM) is the most common acquired
myopathy in those aged above 50. It is classically heralded by weakness in the long finger …

Fingolimod is an oral sphingosine-1-phosphate receptor modulator approved for the
treatment of active relapsing-remitting multiple sclerosis (RRMS). Recent reports have …

Sporadic inclusion body myositis (IBM) is a progressive condition which commonly affects
patients aged above 40. IBM does not respond to immunosuppression and no proven …

CD8+ encephalitis (CD8+ E) is an emerging and incompletely understood HIV-associated
neurological syndrome, typically presenting as a steroid-responsive subacute …

Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral
amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently …

Background and Aim Brainstem gliomas are rare, accounting for less than 2% of adult
gliomas. They are difficult to diagnose and challenging to treat [Hu et al, 2016]. Here, we …